| Hughes, Thomas E. (Tom) (Navitor Pharmaceuticals 202002 CEO before Zafgen 2008–2017 before Novartis) |
Chief Executive Officer (CEO) |
Navitor Pharmaceuticals Inc. |
United States (USA) |
| Huhle, Doreen (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Huiskamp, Chris (Isarna Therapeutics 202109 CFO) |
Chief Financial Officer (CFO) |
Isarna Therapeutics GmbH |
Germany |
| Huisman, Arnoud (Nuvisan 202209 Managing Director of Nuvisan ICB + Chief Strategy Officer of Nuvisan Group) |
Managing Director |
Nuvisan (Group) |
Germany |
| Huland, Edith (Immunservice GmbH 201205 Managing Director) |
Managing Director |
Immunservice GmbH |
Germany |
| Hulot, Thierry (Merck (DE) 201310– Head of Global Manufacturing + Supply at Merck Serono joined Merck 1995) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Humbey, Olivier (Accovion 201412– Country Director France) |
Regional manager |
Clinipace (Group) |
France |
| Humer, Franz B. (Roche –2014 non-exec Chairman before CEO) |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Hummel, Berthold (Baker McKenzie 202106 before Dechert) |
Attorney / Lawyer |
Baker McKenzie LLP |
United States (USA) |
| Humpf, Hans-Ulrich (Univ Münster 201305 Professor) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Humphries, Paul (Flextronics 201806 President High-reliability Solutions) |
n. a. |
Flextronics (d/b/a Flex) (Group) |
Singapore |
| Humphrys, Emily (Cambridge Research Biochemicals 202305 Managing Director) |
Managing Director |
Biosynth (since 9/22) (Group) |
United Kingdom (GB) |
| Hundle, Bhupinder (Eucodis 200910– VP Marketing and Sales) |
Sales Manager / Marketing Manager |
Biosynth (since 9/22) (Group) |
Austria |
| Hundt, Morten (MIRO Analytical 2018– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
Switzerland |
| Hung, David T. (Roivant Sciences 201704– CEO of Axovant before Medivation 201604 CEO) |
Chief Executive Officer (CEO) |
Sio Gene Therapies Inc. (Nasdaq: SIOX) |
United States (USA) |
| Hunkapiller, Michael (Mike) (Pacific Biosciences 201201–202009 CEO before Alloy Ventures + ABI President RETIRED 12/20) |
Chief Executive Officer (CEO) |
Pacific Biosciences (PacBio) (Group) |
United States (USA) |
| Hunkapiller, Tim (Disocovery Biosciences + Univ of Washington + Caltech) |
Researcher (university / research institute) |
Discovery Biosciences Corporation |
United States (USA) |
| Hunneyball, Ian M. |
n. a. |
Evotec (Group) |
Germany |
| Hunt, Stewart (InSphero 201602 General Manager at InSphero Inc) |
General Manager (management) |
InSphero (Group) |
United States (USA) |
| Hunter, Brian (Coral BioNet 201702 of BioNet Ventures) |
Managing Director |
Coral BioNet (Group) |
Germany |
| Huntsman, Peter R. (Huntsman 201710 CEO) |
n. a. |
Huntsman (Group) |
United States (USA) |
| Hurly, Stephen (Lava Therapeutics 202005 CEO formerly 201307 CEO of Burrill Securities LLC) |
Chief Executive Officer (CEO) |
Lava Therapeutics (Group) |
Netherlands |
| Huser, Monique (Roche 200612) |
n. a. |
Roche (Group) |
Switzerland |
| Huss, Ralf (Bavaria (govt) 202301– Managing Director of BioM before Augsburg Univ Hospital + Definiens + Apceth + Roche) |
Cluster Manager |
Bavaria (govt region) |
Germany |
| Husslein, Volker (GSK 201703 Head Communications at GSK Vaccines GmbH) |
Public Relations Manager / Investor Relations Manager |
GSK (Group) |
Germany |
| Hustert, Elisabeth (Scil) |
n. a. |
Coral BioNet (Group) |
Germany |
| Hutchinson, David B. A. (BioAgency 201102 Managing Director of Jomaa Pharma GmbH) |
Managing Director |
BioAgency AG |
Germany |
| Huth, Johannes (KKR 201506 Head KKR Europea, Afria + Middle East) |
President/Director/Head Business Group/Unit/Division |
KKR (Kohlberg Kravis Roberts) (Group) |
United States (USA) |
| Hutter, Bernd (Berthold Technologies 201107 Head Bioanalytical Instruments) |
President/Director/Head Business Group/Unit/Division |
Berthold Technologies (Group) |
Germany |
| Huuk, Thiemo (GoSilico 202106 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
GoSilico GmbH |
Germany |
| Huxley, Alice (Speedel 200701 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Hušman, Dejan (DenovoMatrix 201902 Managing Director) |
Managing Director |
DenovoMatrix GmbH |
Germany |
| Hübler, Karl (Eucodis Bioscience GmbH 201604 CEO) |
Chief Executive Officer (CEO) |
Biosynth (since 9/22) (Group) |
Austria |
| Hübner, Marc (R-Biopharm 201605 Sales Manager Germany + Austria) |
Sales Manager / Marketing Manager |
R-Biopharm (Group) |
Germany |
| Hübschmann, Hans-Joachim (CTC Analytics 201511 VP Sales Asia before Thermo Fisher) |
Technical Manager |
CTC Analytics AG |
Japan |
| Hüls, Christoph (Merck KGaA 200808– VP Operational Excellence Research before Protagen CEO) |
Research & Development Manager |
Merck (DE) (Group) |
Germany |
| Hyman, Anthony (Max Planck 201901 Group Leader at MPI-CBG Dresden + Co-Founder Dewpoint Therapeutics) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
| Hüppe, Paul (Rehberg Hüppe + Partner 201409 Patent Attorney) |
Patent Attorney |
Rehberg Hüppe + Partner Patentanwälte PartG mbB (RHP) |
Germany |
| Hüttl, Reinhard F. (acatech 201002 + Member BioÖkonomieRat) |
Professor |
acatech – Deutsche Akademie der Technikwissenschaften |
Germany |
| Hüttner, Steffen (Hölle & Hüttner 200807 Managing Director + Founder) |
Managing Director |
HB Technologies (Group) |
Germany |
| Hyvelin, Jean-Marc (Stalicla 202002 COO) |
Chief Operating Officer (COO) |
Stalicla S.A. |
Switzerland |
| Hyvert, Jean-Christophe (Lonza 202105 President Biologics and Cell + Gene) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Häckel, Marko (Neoplas GmbH 201206 Managing Director) |
Managing Director |
Neoplas GmbH |
Germany |
| Hämmerle, Hugo (Univ Tübingen 201204 Prof + Head of NMI) |
Researcher (university / research institute) |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Hänggi, Rolf (200808 before Roche VP) |
n. a. |
Roche (Group) |
Switzerland |
| Häßner, Tobias (Tecan Deutschland 200809) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Germany |
| Höfer, Constance (Priaxon 201401– Chief Development Officer before Medigene + Merck KGaA + Solvay) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Priaxon AG |
Germany |
| Höfgen, Norbert (DyNAbind GmbH 201705– Managing Director (COO) + Co-Founder) |
Managing Director |
DyNAbind GmbH |
Germany |
| Höfler, Gerald (Medical Univ Graz 201308 Professor at Institute for Pathology) |
Professor |
Medical University Graz |
Austria |
| Höger, Thomas (Apogenix 200511– CEO + CFO before since 10/00 DZ Bank before BASF/Knoll) |
Chief Executive Officer (CEO) |
Apogenix AG |
Germany |
| Höhling, Axel (ANiMOX GmbH 200810 Managing Director) |
Managing Director |
Animox GmbH |
Germany |
| Höppner, Oliver (KeyNeurotek 200305– before interim management for biotchs + GenProfile AG + Noxxon) |
n. a. |
KeyNeurotek (Group) |
Germany |
| Iacone, Roberto (Alentis Therapeutics 202007– CEO before Versant Ventures + Roche) |
Chief Executive Officer (CEO) |
Alentis Therapeutics AG |
Switzerland |
| Iann, Max Markus (Iann 2012– Founder) |
Investment Manager |
Iann (Group) |
Germany |
| Iannone, Lucio (Bayer 201904 at Leaps by Bayer) |
Investment Manager |
Bayer (Group) |
|
| Ibbotson, Peter (Swisscom 202209 Partner at Swisscom Ventures) |
Partner (venture partner) |
Swisscom (Group) |
Switzerland |
| Ibrahim, Adrian (Wellcome Trust 202101 Head of Technology Transfer + Business Development at Sanger Institute) |
IP Manager |
Wellcome Trust, The |
United Kingdom (GB) |
| Icheln, Bärbel (Peptrotech GmbH 200705) |
n. a. |
Thermo Fisher (Group) |
Germany |
| Ietsugu, Hisashi (Sysmex 200602 CEO) |
Chief Executive Officer (CEO) |
Sysmex (Group) |
Japan |
| Ikeura, Yoshinori (Axcelead 201810 CEO) |
Chief Executive Officer (CEO) |
Axcelead Drug Discovery Partners Inc. (JP) |
Japan |
| Illek, Elmar (Bruker 201407 SVP Bruker Daltonics Commercial Operations before Thermo Fisher) |
Chief Commercial Officer (CCO) |
Bruker (Group) |
Germany |
| Illich, Damir J. (Wille 202210) |
Investment Manager |
Wille Finance AG |
Switzerland |
| Imbert, Tristan (Cimeio Therapeutics 202112 CFO before Novartis Gene Therapies + BCG + Aventis) |
Chief Financial Officer (CFO) |
Cimeio Therapeutics AG |
Switzerland |
| Imhof, Axel (LMU München 201504 Professor) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Imhof, René (Roche 200512) |
n. a. |
Roche (Group) |
Switzerland |
| Imhoff, Johannes F. (Leibniz-Gemeinschaft 201106 Professor + Head KiWiZ at IFM-GEOMAR) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| In-Albon, Beat (Lonza 201206– COO Life Science Ingredients sector before SGS 2006–2012 before Lonza) |
Chief Operating Officer (COO) |
Lonza (Group) |
Switzerland |
| Incerti, Carlo (Forbion 201901– Operating Partner before Sanofi Genzyme + Genzyme + Biofil Srl) |
Partner (venture partner) |
Forbion (Group) |
Netherlands |
| Ingendoh, Arnd (Syft Technologies 202101– VP Sales Europe before Bruker VP Life Sciences MS Sales EMEA + Thermo Fisher) |
Sales Manager / Marketing Manager |
Syft Technologies (Group) |
Germany |
| Ingram, Douglas S. (Doug) (Sarepta Therapeutics 201902 CEO) |
Chief Executive Officer (CEO) |
Sarepta Therapeutics Inc. (NASDAQ: SRPT) |
United States (USA) |
| Ingram, Piers (Hummingbird Bioscience 202105 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Hummingbird Bioscience (SG) |
Singapore |
| Ingvarsson, Staffan (Stockholm (govt) 202306 CEO of Stockholm Business Region) |
Chief Executive Officer (CEO) |
Stockholm (govt city) |
Sweden |
| Ingwers, Matthias (Calibre Scientific 202303 President of Operations Continental Europe) |
President/Director/Head Business Group/Unit/Division |
Calibre Scientific (Group) |
Germany |
| Irsfeld, Marcus (iOmx Therapeutics 201910– CFO before ProCorde GmbH + Averitas Pharma Inc) |
Chief Financial Officer (CFO) |
iOmx Therapeutics AG |
Germany |
| Irvine, Alistair (Kuros 201508 CBO) |
Chief Business Officer (CBO) |
Kuros (Group) |
Switzerland |
| Ischia, Walter (Innerspace 202111 Managing Director) |
Managing Director |
Innerspace GmbH |
Austria |
| Iseli, Bernhard (Tecan –200803) |
n. a. |
Tecan (Group) |
Switzerland |
| Ishida, Noriaki (Daiichi Sankyo 201512 VP Corp Communications Dept) |
Public Relations Manager / Investor Relations Manager |
Daiichi Sankyo (Group) |
Japan |
| Ishnazarova, Nadiya (Merck (DE) 202303 at M Ventures) |
n. a. |
Merck (DE) (Group) |
Netherlands |
| Islam, Khalid (Gentium 200912– CEO before Arpida 199907–200805 CEO) |
Chief Executive Officer (CEO) |
Jazz Pharmaceuticals (Group) |
Italy |
| Itescu, Silviu (Mesoblast 201109 CEO) |
Chief Executive Officer (CEO) |
Mesoblast Ltd. (ASX: MSB, Nasdaq: MESO) |
Australia |
| Itin, Alexander (JSC Valenta Pharmaceuticals 201309 CEO) |
Chief Executive Officer (CEO) |
JSC Valenta Pharmaceuticals |
Russian Federation |
| Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc) |
Chief Executive Officer (CEO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
United Kingdom (GB) |
| Itschert, Frank (BSSN Software GmbH 201908 Managing Director) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Ittig, Simon Josef (T3 Pharmaceuticals 201909 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
T3 Pharmaceuticals AG |
Switzerland |
| Iva, Maryline (BeiGene 202205 Media Relations) |
Public Relations Manager / Investor Relations Manager |
BeiGene (Group) |
Switzerland |
| Ivanov, Igor (OncoLead 201012 Managing Director) |
Managing Director |
OncoLead (Group) |
Germany |
| Ivarrson, Mattias (Inositec 201610 CEO) |
Chief Executive Officer (CEO) |
Vifor Pharma (Group) |
Switzerland |
| Ivarsson, Carl-Johan (Qlucore AB 201209 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Qlucore (Group) |
Sweden |
| Iversen, Morten E. (Sandwater 202310 Partner) |
Partner (venture partner) |
Sandwater (NO) |
Norway |
| Iyer, Mohan (Second Genome 201503 CBO) |
Chief Business Officer (CBO) |
Second Genome Inc. |
United States (USA) |
| Izzo, Marina (EBAMed 202101– CEO before Cardionovum + Symetis + Medtronic Europe + St Jude Medical) |
Chief Executive Officer (CEO) |
EBAMed S.A. |
Switzerland |
| Jabbour, Jerome D. (Jerry) (Matinas BioPharma 202204 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Matinas BioPharma (Group) |
United States (USA) |
| Jablonka, Bernd (Sanofi 201710 Strategy + Business Development, Public Private Partnership Sanofi Germany) |
Business Development Manager / Strategy Manager |
Sanofi (Group) [since May 2011] |
Germany |
| Jacanin, Laura (Genezen 202201– Senior Director Business Development before Cytovance + Lonza + Wuxi) |
Business Development Manager / Strategy Manager |
Genezen Inc. (Genezen Laboratories) |
United States (USA) |
| Jackson, Oliver (Peel Hunt 201707) |
n. a. |
Peel Hunt LLP |
United Kingdom (GB) |
| Jacob, Tobias (High-Tech Gründerfonds 202305 Senior Marketing + Communications Manager) |
Public Relations Manager / Investor Relations Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Jacobi, Philipp (Quadriga Capital 201811 Managing Partner) |
Managing Partner (investment firm) |
Quadriga Capital Eigenkapitalberatung GmbH |
|
| Jacobs, Bruce (Kymera Therapeutics 201907– CFO before Westfield Capital Management + Alex Brown & Sons/Deutsche Bank) |
Chief Financial Officer (CFO) |
Kymera Therapeutics Inc. (Nasdaq: KYMR) |
United States (USA) |
| Jacobs, Elena M. (Eppendorf 201409) |
n. a. |
Eppendorf (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 33 34 35 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
